An interventional study of Progressive Muscle Relaxation Exercise and Kinesio Taping in Premenstrual Syndrome, sponsored by ASLI ER KORUCU. Completed at 1 site in Turkey (Türkiye). Open to female participants. Per ClinicalTrials.gov, last updated 2026-08-27.
Sponsored by ASLI ER KORUCU · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 62 studies in Premenstrual Syndrome with a site in Turkey — 10 open to participants now, 11 under way, none of them phase 3. Premenstrual Syndrome · Turkey.
Among the 62 studies in Premenstrual Syndrome with a site in Turkey, this one is the 3rd largest by enrollment of the 58 interventional ones that give a count, is one of 2 that started in 2017, is one of 58 with no phase, and was the 61st registered.
177 studies on the registry are indexed under Premenstrual Syndrome; 32 are open to participants now.
Browse Premenstrual Syndrome studies →10 of the 62 studies in Premenstrual Syndrome with a site in Turkey are open now. Recruiting first, the newest first:
Nigde Omer Halisdemir University · Sites in Turkey
Ages 18–30 · Women only · Healthy volunteers
Saglik Bilimleri Universitesi · Sites in Turkey
Ages 18–30 · Women only · Healthy volunteers
Eskisehir Osmangazi University · Sites in Turkey
Ages 18–25 · Women only · Healthy volunteers
Izmir Democracy University · Sites in Turkey
Ages 18+ · Women only
Kırklareli University · Sites in Turkey
Ages 18–25 · Women only · Healthy volunteers
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 11 Premenstrual Syndrome studies recruiting now, none (0%) set no upper age limit and 11 (100%) stop at 75 or younger; none take children under 18; 9 take healthy volunteers.
This study: female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
62 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 2 started in 2017.
This study's enrollment of 194 is above the median of 70 across 154 interventional studies indexed under Premenstrual Syndrome.
Median enrollment 76 across the 58 interventional studies, 182 across the 4 observational. Of the 49 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 62 has an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with ASLI ER KORUCU as lead sponsor.
ASLI ER KORUCU has 1 study filed under Premenstrual Syndrome — fewer than ten, so there is no comparison to draw.
3 of the studies in Premenstrual Syndrome with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07409337Nigde Omer Halisdemir UniversitySelf-Acupressure for Primary Dysmenorrhea and Premenstrual Symptoms | 2026-12-15 |
| NCT07814807Izmir Democracy UniversityThe Effects of Manual Lymphatic Drainage and Self-Manual Lymphatic Drainage | 2027-05-05 |
| NCT07785622Kırklareli UniversityThe Effect of Mandala Coloring, Sleep Quality, Anxiety With Premenstrual Syndrome | 2027-06-15 |
Add all 3 to your calendar (.ics) → With an account.
Among the 62 studies in Premenstrual Syndrome with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This randomized controlled trial evaluated the effects of progressive muscle relaxation exercise, kinesio taping, and their combined application on premenstrual symptoms, perceived stress, severity of depressive symptoms, and sleep quality among university students with premenstrual syndrome. Participants were randomly assigned to progressive muscle relaxation, kinesio taping, combined progressive muscle relaxation and kinesio taping, or a control group. The interventions were implemented for 8 weeks. Outcomes were assessed at baseline, immediately after the intervention, and 1 month after completion of the intervention.
This four-arm, parallel-group randomized controlled trial was conducted among students from 13 faculties of Ankara University who met the eligibility criteria for premenstrual syndrome. Eligible participants were randomly assigned in a 1:1:1:1 ratio, using faculty-stratified randomization, to progressive muscle relaxation exercise, kinesio taping, combined progressive muscle relaxation exercise and kinesio taping, or a control group.
The interventions were implemented over 8 weeks. Assessments were conducted at baseline, immediately after the 8-week intervention, and 1 month after completion of the intervention. Premenstrual symptoms were assessed as the primary outcome. Perceived stress, depressive symptoms, and sleep quality were assessed as secondary outcomes.
A total of 180 participants were initially randomized, with 45 participants assigned to each group. During the first intervention cycle, 14 participants discontinued the study: 2 from the control group, 4 from the kinesio taping group, 5 from the progressive muscle relaxation group, and 3 from the combined intervention group. Fourteen additional eligible participants were subsequently enrolled and allocated to the corresponding groups using the same faculty-stratified approach. Therefore, the total number of unique enrolled participants was 194. A total of 180 participants, 45 in each group, completed all assessments and were included in the complete-case analyses.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants performed progressive muscle relaxation exercises for 8 weeks.
Behavioral: Progressive Muscle Relaxation Exercise
Participants received kinesio taping for 8 weeks
Device: Kinesio Taping
Participants received both progressive muscle relaxation exercise and kinesio taping for 8 weeks.
Behavioral: Progressive Muscle Relaxation Exercise · Device: Kinesio Taping
Participants received no study intervention and completed assessments at the same time points as the intervention groups.
Participants received supervised progressive muscle relaxation exercise involving the sequential tensing and relaxing of 16 muscle groups together with deep-breathing techniques. Two consecutive 20-minute sessions were conducted at each visit, resulting in 40 minutes of exercise. The intervention was delivered twice weekly for 8 weeks, for a total of 16 visits, and was initiated after menstrual bleeding had ended.
Also known as: PMR
During the luteal phase, an 8-cm strip of kinesio tape was applied vertically along the lower abdominal midline, and a 10-cm strip was applied horizontally across the vertical strip. The middle sections were applied with 25% tension, whereas the ends were applied without tension. The tape was replaced every 4 days during the luteal phase over two menstrual cycles and was reapplied if it detached prematurely. Each application lasted approximately 15 minutes, including preparation and participant instruction.
Also known as: KT
Premenstrual Syndrome Scale
Premenstrual symptom severity was assessed using the 44-item Premenstrual Syndrome Scale (PMSS). Each item is scored from 1 to 5, yielding a total score ranging from 44 to 220. Higher scores indicate greater premenstrual symptom severity.
Time frame: Baseline, immediately after the 8-week intervention, and 1 month after completion of the intervention
Perceived Stress Scale
Perceived stress was assessed using the 14-item Perceived Stress Scale (PSS). Each item is scored from 0 to 4, with seven positively worded items reverse-scored, yielding a total score ranging from 0 to 56. Higher scores indicate higher levels of perceived stress.
Time frame: Baseline, immediately after the 8-week intervention, and 1 month after completion of the intervention
Beck Depression Inventory
Depressive symptom severity was assessed using the 21-item Beck Depression Inventory (BDI). Each item is scored from 0 to 3, yielding a total score ranging from 0 to 63. Higher scores indicate greater severity of depressive symptoms. The inventory was used to assess symptom severity and not to establish a clinical diagnosis of depression.
Time frame: Baseline, immediately after the 8-week intervention, and 1 month after completion of the intervention
Pittsburgh Sleep Quality Index
Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI). Seven component scores derived from 19 self-reported items are summed to yield a total score ranging from 0 to 21. Higher scores indicate poorer sleep quality, and a total score greater than 5 indicates poor sleep quality.
Time frame: Baseline, immediately after the 8-week intervention, and 1 month after completion of the intervention
Plan to share: Yes — De-identified individual participant data underlying the results reported in the associated publication will be shared upon approval of a reasonable request. The shared data may include baseline participant characteristics, intervention group assignment, and PMSS, PSS, BDI, and PSQI outcome scores collected at baseline, immediately after the 8-week intervention, and 1 month after completion of the intervention. A data dictionary will also be provided. No directly or indirectly identifying participant information will be shared.
Supporting information: Study protocol
No publications or documents are linked to this record.
Ran from Dec 2017 to primary completion in Aug 2018, 7 months.
Of 76 non-industry interventional studies with no phase under Premenstrual Syndrome, half reached primary completion within 5 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 12. This study's 7 months is above that.
Counting every sponsor, half of 87 studies reached it within 5 months; a quarter within 3 and three quarters within 10.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.